Key Metrics
5
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
Q3
Immunology
SJR
- Q3 Immunology
- Q3 Immunology and Allergy
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
3 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
58%
4 to 6 months
38%
7 to 9 months
0%
Above 9 months
4%
Did you find this useful?
Thank you for your feedback.
Indexed in the following public directories
-
Scopus -
DOAJ -
SJR
Topics Covered
- Tumor microenvironment
- Antibody-drug conjugate
- Downstream processing
- Blocking antibody
- Augmented reality
- Chimeric antigen receptor
- Severe acute respiratory syndrome coronavirus
- Neutralizing antibody
- Angiotensin-converting enzyme
- Human papillomavirus
- Bispecific antibody
- Antiserum
- Pandemic
- Human papillomavirus vaccination
- Monoclonal antibody
- Tumor targeting
- Immune checkpoint inhibitors
- Affinity maturation
Journal Specifications
| Overview | |
| Publisher | Oxford University Press |
| Language | English |
| Article Processing Charges | GBP 1750 | USD 2625 |
| Publication Time | 8 |
| Editorial Review Process | Blind peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | Chinese Antibody Society |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Waiver Policy | Visit website |
| Publication Time | 8 |
| Article Processing Charges | GBP 1750 | USD 2625 |
| Editorial Review Detail | |
| Editorial Team | Visit website |
| Review Process | Blind peer review |
| Review Url | Visit website |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
Planning to publish in Antibody Therapeutics ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Beyond ADCs: Harnessing Bispecific Antibodies to Directly Induce Apoptosis for Targeted Tumor Eradication
- 29 Oct 24
- Antibody Therapeutics
-
Full paper
Leveraging High-Throughput Analytics and Automation to Rapidly Develop High-Concentration mAb Formulations: Integrated Excipient Compatibility and Viscosity Screening
- 12 Oct 24
- Antibody Therapeutics
-
Full paper
Discovery of a common light chain bispecific antibody targeting PD-1 and PD-L1 by Hybridoma-to-phage-to-yeast (H2PtY) platform
- 10 Oct 24
- Antibody Therapeutics
-
Full paper
AI-based antibody discovery platform identifies novel, diverse, and pharmacologically active therapeutic antibodies against multiple SARS-CoV-2 strains.
- 26 Sep 24
- Antibody therapeutics
-
Full paper
Directed protein engineering identifies a human TIM-4 blocking antibody that enhances anti-tumor response to checkpoint inhibition in murine colon carcinoma
- 23 Sep 24
- Antibody Therapeutics
-
Full paper
FcRider: a recombinant Fc nanoparticle with endogenous adjuvant activities for hybrid immunization.
- 6 Sep 24
- Antibody therapeutics
Scite analysis
Powered by scite_
198 articles received 1.8k citations see all
- 27 Supporting
- 1,768 Mentioning
- 1 Contrasting
Editorial notices
- 0 Retractions
- 0 Withdrawals
- 2 Corrections
- 2 Errata
- 0 Expression of Concern
FAQs
How many articles did Antibody Therapeutics publish last years ?
In 2023, Antibody Therapeutics published 57 articles.
What is Citescore for Antibody Therapeutics ?
Citescore for Antibody Therapeutics is 5.
What is the SJR for Antibody Therapeutics ?
SJR for Antibody Therapeutics is Q3.
Who is the publisher of Antibody Therapeutics ?
Oxford University Press is the publisher of Antibody Therapeutics.